Baxter International BAX Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.
The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Baxter International's stock issuance proceeds?
- Baxter International (BAX) reported stock issuance proceeds of $8M in Q1 2026.
- How has Baxter International's stock issuance proceeds changed year-over-year?
- Baxter International's stock issuance proceeds decreased by 20.0% year-over-year, from $10M to $8M.
- What is the long-term trend for Baxter International's stock issuance proceeds?
- Over 4 years (2021 to 2025), Baxter International's stock issuance proceeds has grown at a -36.7% compound annual growth rate (CAGR), from $187M to $30M.
- What does stock issuance proceeds mean?
- Cash received from selling company stock or issuing shares to employees.
- How do you interpret stock issuance proceeds?
- Higher proceeds from public offerings may indicate a need for capital, whereas proceeds from employee plans reflect standard compensation practices.
- How does stock issuance proceeds compare across companies?
- Common across large-cap healthcare firms, often tied to stock-based compensation expense levels.